ATE258808T1 - Schaumbildender wundverband - Google Patents

Schaumbildender wundverband

Info

Publication number
ATE258808T1
ATE258808T1 AT01912909T AT01912909T ATE258808T1 AT E258808 T1 ATE258808 T1 AT E258808T1 AT 01912909 T AT01912909 T AT 01912909T AT 01912909 T AT01912909 T AT 01912909T AT E258808 T1 ATE258808 T1 AT E258808T1
Authority
AT
Austria
Prior art keywords
foam
wound dressing
wound
prepared
dressing
Prior art date
Application number
AT01912909T
Other languages
English (en)
Inventor
David Sierra
Original Assignee
David Sierra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David Sierra filed Critical David Sierra
Application granted granted Critical
Publication of ATE258808T1 publication Critical patent/ATE258808T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/07—Stiffening bandages
    • A61L15/12—Stiffening bandages containing macromolecular materials
    • A61L15/125—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01912909T 2000-02-25 2001-02-21 Schaumbildender wundverband ATE258808T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18499700P 2000-02-25 2000-02-25
PCT/US2001/005624 WO2001062312A1 (en) 2000-02-25 2001-02-21 Foam-forming wound dressing

Publications (1)

Publication Number Publication Date
ATE258808T1 true ATE258808T1 (de) 2004-02-15

Family

ID=22679125

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01912909T ATE258808T1 (de) 2000-02-25 2001-02-21 Schaumbildender wundverband

Country Status (9)

Country Link
EP (1) EP1257304B1 (de)
JP (1) JP2003523409A (de)
AT (1) ATE258808T1 (de)
AU (1) AU2001241644A1 (de)
CA (1) CA2399211A1 (de)
DE (1) DE60101956T2 (de)
HK (1) HK1047898A1 (de)
IL (1) IL151245A0 (de)
WO (1) WO2001062312A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846141B2 (en) 2002-09-03 2010-12-07 Bluesky Medical Group Incorporated Reduced pressure treatment system
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
GB0403406D0 (en) * 2004-02-17 2004-03-24 Biotransys Ltd Preparation of carriers for drug delivery and other therapeutic applications
US8062272B2 (en) 2004-05-21 2011-11-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US7909805B2 (en) 2004-04-05 2011-03-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US10058642B2 (en) 2004-04-05 2018-08-28 Bluesky Medical Group Incorporated Reduced pressure treatment system
GB0409446D0 (en) 2004-04-28 2004-06-02 Smith & Nephew Apparatus
GB2444323B (en) * 2006-11-30 2011-04-06 Ethicon Inc Protein sheet material
CN104382691B (zh) 2007-11-21 2018-08-31 史密夫及内修公开有限公司 伤口包敷物
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
WO2009067711A2 (en) 2007-11-21 2009-05-28 T.J. Smith & Nephew, Limited Suction device and dressing
US20130096518A1 (en) 2007-12-06 2013-04-18 Smith & Nephew Plc Wound filling apparatuses and methods
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
GB0723875D0 (en) 2007-12-06 2008-01-16 Smith & Nephew Wound management
GB0803564D0 (en) 2008-02-27 2008-04-02 Smith & Nephew Fluid collection
GB0902816D0 (en) 2009-02-19 2009-04-08 Smith & Nephew Fluid communication path
WO2010137043A1 (en) * 2009-05-27 2010-12-02 Baxter Manufacturing S.P.A. Haemostatic biomaterial from waste fractions of human plasma fractionation process
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
CN107033596A (zh) 2010-11-25 2017-08-11 史密夫及内修公开有限公司 组合物i – ii及其产品和用途
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
MX356867B (es) * 2012-12-07 2018-06-18 Baxter Healthcare Sa Espuma hemostatica.
EP2968647B1 (de) 2013-03-15 2022-06-29 Smith & Nephew plc Wundverbanddichtmasse und verwendung davon
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
WO2017025965A1 (en) 2015-08-13 2017-02-16 Kamada Ltd. Compositions derived from cohn fraction paste and use thereof
CN109789091A (zh) 2016-09-14 2019-05-21 奥姆里克斯生物药品有限公司 稳定的药物泡沫
IL247810A0 (en) 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Stable pharmaceutical foam

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3171072D1 (en) * 1981-06-25 1985-07-25 Stroetmann M Serapharm Enriched plasma derivative for promoting wound sealing and wound covering
ATE215106T1 (de) * 1993-12-01 2002-04-15 Bioartificial Gel Technologies Inc Hydrogel auf basis von albumin
US5583114A (en) * 1994-07-27 1996-12-10 Minnesota Mining And Manufacturing Company Adhesive sealant composition
GB9424562D0 (en) * 1994-12-06 1995-01-25 Giltech Ltd Product
NO953115L (no) * 1995-06-07 1996-12-09 Albany Int Research Fremgangsmåte for fremstilling av polysakkaridskum
WO1998002098A1 (en) * 1996-07-12 1998-01-22 Baxter International Inc. A fibrin delivery device and method for forming fibrin on a surface
CA2335952A1 (en) * 1998-06-23 1999-12-29 Shekharam Tammishetti Carbodiimide cross-linked albumin for bioadhesives, surgical sealants and implantable devices
ES2242631T3 (es) * 1999-07-21 2005-11-16 Imedex Biomateriaux Espuma de una proteina adhesiva para usos quirurgicos y/o terapeuticos.

Also Published As

Publication number Publication date
HK1047898A1 (zh) 2003-03-14
EP1257304B1 (de) 2004-02-04
EP1257304A1 (de) 2002-11-20
AU2001241644A1 (en) 2001-09-03
IL151245A0 (en) 2003-04-10
JP2003523409A (ja) 2003-08-05
CA2399211A1 (en) 2001-08-30
WO2001062312A1 (en) 2001-08-30
DE60101956D1 (de) 2004-03-11
DE60101956T2 (de) 2004-12-23

Similar Documents

Publication Publication Date Title
DE60101956D1 (de) Schaumbildender wundverband
ATE269113T1 (de) Sprühfähige wundversorgungszusammensetzung
WO2000038626A3 (en) Substrate composition and method of use for sequestration of skin irritants
NO971192L (no) Fremgangsmåter for avlevering av materialer inn i huden, og sammensetninger som blir anvendt
HRP20030904A2 (en) Liquid formulations for dermal application in treatment of parasitic insects in animals
MXPA02005797A (es) Metodos y dispositivos electroquimicos para su uso en la determinacion de concentraciones de analitos con hematocrito corregido.
TR199801390T2 (xx) Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler
ATE340844T1 (de) Stabile, wässerige zusammensetzungen zur behandlung von oberflächen , insbesondere geweben
DE69512685D1 (de) Mittel zur verabreichung von wirksubstanzen an bzw. durch die haut
ATE540976T1 (de) Antikörper zur inhibierung der blutgerinnung und verfahren zur deren verwendung
NO950051L (no) Plaster for lavtsmeltende og/eller flyktige aktive bestanddeler
DE50006156D1 (de) Vorrichtung und verwendung zur steigerung der transdermalen permeation von arzneistoffen
WO2002055098A3 (en) Latency associated peptide for providing latency to pharmaceutically active proteins
AU9446498A (en) Reducing agent with several constituents comprising at least a composition in powder form containing an agent for reducing hair sulphur bonds and method for permanent setting of keratin fibres
ATE357205T1 (de) Verfahren zur erhöhung der schwellentoleranz bei empfindlicher haut
MXPA04000770A (es) Gel apara afeitar que se presenta en forma diferente al aerosol.
ATE345160T1 (de) Topisches produkt mit visuellem indikator
DE60133005D1 (de) Haltbare kosmetische zusammensetzung, die ein bestimmtes haftungsförderndes material enthält
WO2003037288A3 (fr) Composition cosmetique mimant le sebum, et utilisations
AU7440401A (en) Methods and devices for in situ formation of vascular structures suitable for use as blood vessels
WO2006053613A3 (en) Skin care composition comprising fusion polypeptide composition
DE60110087D1 (de) Verwendung von Carboanhydrase-Inhibitoren zur Prävention von diabetischer Retinopathie bei Diabetikern
WO2002004521A3 (en) Proteins with integrin-like activity
ATE291068T1 (de) Emulgiertes gel
ATE184199T1 (de) Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties